Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 6/2012

01.06.2012 | Article

Value of PCR in surgically treated patients with staphylococcal infective endocarditis: a 4-year retrospective study

verfasst von: B. Žaloudíková, E. Němcová, J. Pol, Z. Šorm, Š. Wurmová, K. Novotná, M. Vaněrková, V. Holá, F. Růžička, L. Dušek, P. Němec, T. Freiberger

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of the study was to establish a diagnostic value for broad-range polymerase chain reaction (br-PCR) and staphylococci-specific multiplex PCR (ssm-PCR) performed on surgical material from patients with staphylococcal infective endocarditis (IE). Data were analysed retrospectively from 60 patients with suspected staphylococcal IE and 59 controls who were surgically treated at three cardiosurgery centres over 4 years. Both PCR tests showed high agreement and could be aggregated. In patients with definite and rejected IE, the clinical sensitivity and specificity of PCR reached 89 and 95%, respectively. Tissue culture (TC) and PCR agreed with blood culture (BC) in 29% and 67% of IE cases. TC helped to determine aetiology in five BC negative cases while PCR aided in nine cases. Out of 52 patients with conclusive staphylococcal IE, 40 were diagnosed with S. aureus and 12 with coagulase-negative staphylococci. PCR was shown to be highly superior to TC in confirming preoperative diagnosis of IE. In addition to aid in culture negative patients, PCR helped to establish or refine aetiology in inconclusive cases. We suggest that simultaneous br-PCR and ssm-PCR performed on surgical material together with histopathology could significantly increase the performance of current Duke criteria.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Baddour LM, Wilson WR, Bayer AS, Fowler VG, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA, Committee on Rheumatic Fever Ed, and Kawasaki Disease, Young CoCDit, Councils on Clinical Cardiology Sr, and Cardiovascular Surgery and Anesthesia, Association AH, America IDSo (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111(23):e394–e434PubMedCrossRef Baddour LM, Wilson WR, Bayer AS, Fowler VG, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA, Committee on Rheumatic Fever Ed, and Kawasaki Disease, Young CoCDit, Councils on Clinical Cardiology Sr, and Cardiovascular Surgery and Anesthesia, Association AH, America IDSo (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111(23):e394–e434PubMedCrossRef
2.
Zurück zum Zitat Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL, Guidelines ECfP (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for infection and cancer. Eur Heart J 30(19):2369–2413PubMedCrossRef Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL, Guidelines ECfP (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for infection and cancer. Eur Heart J 30(19):2369–2413PubMedCrossRef
3.
Zurück zum Zitat Hill EE, Herijgers P, Herregods MC, Peetermans WE (2006) Evolving trends in infective endocarditis. Clin Microbiol Infect 12(1):5–12PubMedCrossRef Hill EE, Herijgers P, Herregods MC, Peetermans WE (2006) Evolving trends in infective endocarditis. Clin Microbiol Infect 12(1):5–12PubMedCrossRef
4.
Zurück zum Zitat Pazdernik M, Baddour LM, Pelouch R (2009) Infective endocarditis in the Czech Republic: eight years of experience at one of the country's largest medical centers. J Heart Valve Dis 18(4):395–400PubMed Pazdernik M, Baddour LM, Pelouch R (2009) Infective endocarditis in the Czech Republic: eight years of experience at one of the country's largest medical centers. J Heart Valve Dis 18(4):395–400PubMed
5.
Zurück zum Zitat Fernandez Guerrero M, Gonzalez Lopez J, Goyenechea A, Fraile J, de Gorgolas M (2009) Endocarditis caused by Staphylococcus aureus a reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome. Medicine (Baltimore) 88(1):1–22 Fernandez Guerrero M, Gonzalez Lopez J, Goyenechea A, Fraile J, de Gorgolas M (2009) Endocarditis caused by Staphylococcus aureus a reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome. Medicine (Baltimore) 88(1):1–22
6.
Zurück zum Zitat Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, Olaison L, Eykyn S, Hoen B, Abrutyn E, Raoult D, Bayer A, Fowler VG, Group ICoEMDS (2005) Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 41(4):507–514PubMedCrossRef Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, Olaison L, Eykyn S, Hoen B, Abrutyn E, Raoult D, Bayer A, Fowler VG, Group ICoEMDS (2005) Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 41(4):507–514PubMedCrossRef
7.
Zurück zum Zitat Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS, Investigators I (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293(24):3012–3021PubMedCrossRef Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS, Investigators I (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293(24):3012–3021PubMedCrossRef
8.
Zurück zum Zitat Chu VH, Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA, Federspiel J, Athan E, Stryjewski ME, Nacinovich F, Marco F, Levine DP, Elliott TS, Fortes CQ, Tornos P, Gordon DL, Utili R, Delahaye F, Corey GR, Fowler VG, Group ICoE-PCS (2008) Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 46(2):232–242PubMedCrossRef Chu VH, Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA, Federspiel J, Athan E, Stryjewski ME, Nacinovich F, Marco F, Levine DP, Elliott TS, Fortes CQ, Tornos P, Gordon DL, Utili R, Delahaye F, Corey GR, Fowler VG, Group ICoE-PCS (2008) Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 46(2):232–242PubMedCrossRef
9.
Zurück zum Zitat Chu VH (2008) Coagulase-negative staphylococci and endocarditis: reappraisal in the 21st century. Enferm Infecc Microbiol Clin 26(5):261–262PubMedCrossRef Chu VH (2008) Coagulase-negative staphylococci and endocarditis: reappraisal in the 21st century. Enferm Infecc Microbiol Clin 26(5):261–262PubMedCrossRef
10.
Zurück zum Zitat Lalani T, Kanafani ZA, Chu VH, Moore L, Corey GR, Pappas P, Woods CW, Cabell CH, Hoen B, Selton-Suty C, Doco-Lecompte T, Chirouze C, Raoult D, Miro JM, Mestres CA, Olaison L, Eykyn S, Abrutyn E, Fowler VG, Group ICoEMDS (2006) Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database. Eur J Clin Microbiol Infect Dis 25(6):365–368PubMedCrossRef Lalani T, Kanafani ZA, Chu VH, Moore L, Corey GR, Pappas P, Woods CW, Cabell CH, Hoen B, Selton-Suty C, Doco-Lecompte T, Chirouze C, Raoult D, Miro JM, Mestres CA, Olaison L, Eykyn S, Abrutyn E, Fowler VG, Group ICoEMDS (2006) Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database. Eur J Clin Microbiol Infect Dis 25(6):365–368PubMedCrossRef
11.
Zurück zum Zitat Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH, Investigators ICoE-PCSI-P (2009) Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169(5):463–473PubMedCrossRef Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH, Investigators ICoE-PCSI-P (2009) Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169(5):463–473PubMedCrossRef
12.
Zurück zum Zitat Hill EE, Peetermans WE, Vanderschueren S, Claus P, Herregods MC, Herijgers P (2008) Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis. Eur J Clin Microbiol Infect Dis 27(6):445–450PubMedCrossRef Hill EE, Peetermans WE, Vanderschueren S, Claus P, Herregods MC, Herijgers P (2008) Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis. Eur J Clin Microbiol Infect Dis 27(6):445–450PubMedCrossRef
13.
Zurück zum Zitat Chu VH, Miro JM, Hoen B, Cabell CH, Pappas PA, Jones P, Stryjewski ME, Anguera I, Braun S, Muñoz P, Commerford P, Tornos P, Francis J, Oyonarte M, Selton-Suty C, Morris AJ, Habib G, Almirante B, Sexton DJ, Corey GR, Fowler VG, Group ICoE-PCS (2009) Coagulase-negative staphylococcal prosthetic valve endocarditis—a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study. Heart 95(7):570–576PubMedCrossRef Chu VH, Miro JM, Hoen B, Cabell CH, Pappas PA, Jones P, Stryjewski ME, Anguera I, Braun S, Muñoz P, Commerford P, Tornos P, Francis J, Oyonarte M, Selton-Suty C, Morris AJ, Habib G, Almirante B, Sexton DJ, Corey GR, Fowler VG, Group ICoE-PCS (2009) Coagulase-negative staphylococcal prosthetic valve endocarditis—a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study. Heart 95(7):570–576PubMedCrossRef
14.
Zurück zum Zitat Watkin R, Lang S, Lambert P, Littler W, Elliott T (2003) The microbial diagnosis of infective endocarditis. J Infect 47(1):1–11 Watkin R, Lang S, Lambert P, Littler W, Elliott T (2003) The microbial diagnosis of infective endocarditis. J Infect 47(1):1–11
15.
Zurück zum Zitat Munoz P, Bouza E, Marin M, Alcala L, Rodriguez Creixems M, Valerio M, Pinto A (2008) Heart valves should not be routinely cultured. J Clin Microbiol 46(9):2897–2901PubMedCrossRef Munoz P, Bouza E, Marin M, Alcala L, Rodriguez Creixems M, Valerio M, Pinto A (2008) Heart valves should not be routinely cultured. J Clin Microbiol 46(9):2897–2901PubMedCrossRef
16.
Zurück zum Zitat Naber CK, Erbel R (2007) Infective endocarditis with negative blood cultures. Int J Antimicrob Agents 30(Suppl 1):S32–S36PubMedCrossRef Naber CK, Erbel R (2007) Infective endocarditis with negative blood cultures. Int J Antimicrob Agents 30(Suppl 1):S32–S36PubMedCrossRef
17.
Zurück zum Zitat Podglajen I, Bellery F, Poyart C, Coudol P, Buu-Hoï A, Bruneval P, Mainardi JL (2003) Comparative molecular and microbiologic diagnosis of bacterial endocarditis. Emerg Infect Dis 9(12):1543–1547PubMed Podglajen I, Bellery F, Poyart C, Coudol P, Buu-Hoï A, Bruneval P, Mainardi JL (2003) Comparative molecular and microbiologic diagnosis of bacterial endocarditis. Emerg Infect Dis 9(12):1543–1547PubMed
18.
Zurück zum Zitat Marin M, Munoz P, Sanchez M, del Rosal M, Alcala L, Rodriguez-Creixems M, Bouza E (2007) Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore) 86(4):195–202CrossRef Marin M, Munoz P, Sanchez M, del Rosal M, Alcala L, Rodriguez-Creixems M, Bouza E (2007) Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore) 86(4):195–202CrossRef
19.
Zurück zum Zitat Vondracek M, Sartipy U, Aufwerber E, Julander I, Lindblom D, Westling K (2011) 16S rDNA sequencing of valve tissue improves microbiological diagnosis in surgically treated patients with infective endocarditis. J Infect 62(6):472–478PubMedCrossRef Vondracek M, Sartipy U, Aufwerber E, Julander I, Lindblom D, Westling K (2011) 16S rDNA sequencing of valve tissue improves microbiological diagnosis in surgically treated patients with infective endocarditis. J Infect 62(6):472–478PubMedCrossRef
20.
Zurück zum Zitat Lang S, Watkin R, Lambert P, Bonser R, Littler W, Elliott T (2004) Evaluation of PCR in the molecular diagnosis of endocarditis. J Infect 48(3):269–275 Lang S, Watkin R, Lambert P, Bonser R, Littler W, Elliott T (2004) Evaluation of PCR in the molecular diagnosis of endocarditis. J Infect 48(3):269–275
21.
Zurück zum Zitat Voldstedlund M, Nørum Pedersen L, Baandrup U, Klaaborg KE, Fuursted K (2008) Broad-range PCR and sequencing in routine diagnosis of infective endocarditis. APMIS 116(3):190–198PubMedCrossRef Voldstedlund M, Nørum Pedersen L, Baandrup U, Klaaborg KE, Fuursted K (2008) Broad-range PCR and sequencing in routine diagnosis of infective endocarditis. APMIS 116(3):190–198PubMedCrossRef
22.
Zurück zum Zitat Gauduchon V, Chalabreysse L, Etienne J, Célard M, Benito Y, Lepidi H, Thivolet-Béjui F, Vandenesch F (2003) Molecular diagnosis of infective endocarditis by PCR amplification and direct sequencing of DNA from valve tissue. J Clin Microbiol 41(2):763–766PubMedCrossRef Gauduchon V, Chalabreysse L, Etienne J, Célard M, Benito Y, Lepidi H, Thivolet-Béjui F, Vandenesch F (2003) Molecular diagnosis of infective endocarditis by PCR amplification and direct sequencing of DNA from valve tissue. J Clin Microbiol 41(2):763–766PubMedCrossRef
23.
Zurück zum Zitat Li J, Sexton D, Mick N, Nettles R, Fowler V, Ryan T, Bashore T, Corey G (2000) Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30(4):633–638 Li J, Sexton D, Mick N, Nettles R, Fowler V, Ryan T, Bashore T, Corey G (2000) Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30(4):633–638
24.
Zurück zum Zitat Grijalva M, Horváth R, Dendis M, Erný J, Benedík J (2003) Molecular diagnosis of culture negative infective endocarditis: clinical validation in a group of surgically treated patients. Heart 89(3):263–268PubMedCrossRef Grijalva M, Horváth R, Dendis M, Erný J, Benedík J (2003) Molecular diagnosis of culture negative infective endocarditis: clinical validation in a group of surgically treated patients. Heart 89(3):263–268PubMedCrossRef
25.
Zurück zum Zitat Jonas D, Speck M, Daschner FD, Grundmann H (2002) Rapid PCR-based identification of methicillin-resistant Staphylococcus aureus from screening swabs. J Clin Microbiol 40(5):1821–1823PubMedCrossRef Jonas D, Speck M, Daschner FD, Grundmann H (2002) Rapid PCR-based identification of methicillin-resistant Staphylococcus aureus from screening swabs. J Clin Microbiol 40(5):1821–1823PubMedCrossRef
26.
Zurück zum Zitat Mason WJ, Blevins JS, Beenken K, Wibowo N, Ojha N, Smeltzer MS (2001) Multiplex PCR protocol for the diagnosis of staphylococcal infection. J Clin Microbiol 39(9):3332–3338PubMedCrossRef Mason WJ, Blevins JS, Beenken K, Wibowo N, Ojha N, Smeltzer MS (2001) Multiplex PCR protocol for the diagnosis of staphylococcal infection. J Clin Microbiol 39(9):3332–3338PubMedCrossRef
27.
Zurück zum Zitat Rovery C, Greub G, Lepidi H, Casalta JP, Habib G, Collart F, Raoult D (2005) PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis. J Clin Microbiol 43(1):163–167PubMedCrossRef Rovery C, Greub G, Lepidi H, Casalta JP, Habib G, Collart F, Raoult D (2005) PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis. J Clin Microbiol 43(1):163–167PubMedCrossRef
28.
Zurück zum Zitat Greub G, Lepidi H, Rovery C, Casalta J, Habib G, Collard F, Fournier P, Raoult D (2005) Diagnosis of infectious endocarditis in patients undergoing valve surgery. Am J Med 118(3):230–238 Greub G, Lepidi H, Rovery C, Casalta J, Habib G, Collard F, Fournier P, Raoult D (2005) Diagnosis of infectious endocarditis in patients undergoing valve surgery. Am J Med 118(3):230–238
29.
Zurück zum Zitat Qin X, Urdahl K (2001) PCR and sequencing of independent genetic targets for the diagnosis of culture negative bacterial endocarditis. Diagn Microbiol Infect Dis 40(4):145–149 Qin X, Urdahl K (2001) PCR and sequencing of independent genetic targets for the diagnosis of culture negative bacterial endocarditis. Diagn Microbiol Infect Dis 40(4):145–149
30.
Zurück zum Zitat Petti CA, Simmon KE, Miro JM, Hoen B, Marco F, Chu VH, Athan E, Bukovski S, Bouza E, Bradley S, Fowler VG, Giannitsioti E, Gordon D, Reinbott P, Korman T, Lang S, Garcia-de-la-Maria C, Raglio A, Morris AJ, Plesiat P, Ryan S, Doco-Lecompte T, Tripodi F, Utili R, Wray D, Federspiel JJ, Boisson K, Reller LB, Murdoch DR, Woods CW, Investigators ICoE-M (2008) Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. J Clin Microbiol 46(5):1780–1784PubMedCrossRef Petti CA, Simmon KE, Miro JM, Hoen B, Marco F, Chu VH, Athan E, Bukovski S, Bouza E, Bradley S, Fowler VG, Giannitsioti E, Gordon D, Reinbott P, Korman T, Lang S, Garcia-de-la-Maria C, Raglio A, Morris AJ, Plesiat P, Ryan S, Doco-Lecompte T, Tripodi F, Utili R, Wray D, Federspiel JJ, Boisson K, Reller LB, Murdoch DR, Woods CW, Investigators ICoE-M (2008) Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. J Clin Microbiol 46(5):1780–1784PubMedCrossRef
31.
Zurück zum Zitat Tak T, Shukla SK (2004) Molecular diagnosis of infective endocarditis: a helpful addition to the Duke criteria. Clin Med Res 2(4):206–208PubMedCrossRef Tak T, Shukla SK (2004) Molecular diagnosis of infective endocarditis: a helpful addition to the Duke criteria. Clin Med Res 2(4):206–208PubMedCrossRef
32.
Zurück zum Zitat Millar B, Moore J, Mallon P, Xu J, Crowe M, McClurg R, Raoult D, Earle J, Hone R, Murphy P (2001) Molecular diagnosis of infective endocarditis—a new Duke’s Criterion. Scand J Infect Dis 33(9):673–680 Millar B, Moore J, Mallon P, Xu J, Crowe M, McClurg R, Raoult D, Earle J, Hone R, Murphy P (2001) Molecular diagnosis of infective endocarditis—a new Duke’s Criterion. Scand J Infect Dis 33(9):673–680
Metadaten
Titel
Value of PCR in surgically treated patients with staphylococcal infective endocarditis: a 4-year retrospective study
verfasst von
B. Žaloudíková
E. Němcová
J. Pol
Z. Šorm
Š. Wurmová
K. Novotná
M. Vaněrková
V. Holá
F. Růžička
L. Dušek
P. Němec
T. Freiberger
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 6/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1427-3

Weitere Artikel der Ausgabe 6/2012

European Journal of Clinical Microbiology & Infectious Diseases 6/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.